Jetblue Airways Corp (JBLU) 23.22 $JBLU Airline Stock

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Jetblue Airways Corp (JBLU) 23.22 $JBLU

Airline Stock Roundup: Delta Tops Q2 Earnings, United Continental Trims Domestic Capacity - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 23, 8:51AM CDT
It was a week which saw Delta (DAL) kick-starting the second-quarter 2015 earnings season within the aviation space.
SAVE: 61.37 (+1.32), DAL: 45.16 (-0.06), AAL: 42.61 (+1.18), GOL: 1.68 (-0.13), JBLU: 23.22 (-0.30), UAL: 56.67 (-0.40), LUV: 36.48 (+1.36)

American Express Co. Beats on Earnings, Misses on Revenue Estimates - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Wed Jul 22, 4:23PM CDT
American Express was able to significantly beat on the estimates for the company's earnings, though revenue was slightly lower than expected.
AXP: 77.01 (-1.98), COST: 145.60 (-0.78), JBLU: 23.22 (-0.30)

Coke Cuts Costs, Raises Prices to Offset Sluggish Soda Sales
at The Street - Wed Jul 22, 12:39PM CDT
The company's second-quarter earnings beat estimates, but fell from a year earlier.
KO: 40.84 (-0.06), JBLU: 23.22 (-0.30)

JetBlue Airways Rises 1.44% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Jul 21, 5:18PM CDT
JetBlue Airways (NASDAQ:JBLU) traded in a range yesterday that spanned from a low of $22.71 to a high of $23.23. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $23.10 on volume of 5.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JBLU: 23.22 (-0.30)

Look for Shares of JetBlue Airways to Potentially Pullback after Yesterday's 1.44% Rise
Comtex SmarTrend(R) - Tue Jul 21, 5:17PM CDT
JetBlue Airways (NASDAQ:JBLU) traded in a range yesterday that spanned from a low of $22.71 to a high of $23.23. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $23.10 on volume of 5.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JBLU: 23.22 (-0.30)

American Express' Stock Looks Like a Low-Risk Bet Before Earnings
at The Street - Tue Jul 21, 5:15AM CDT
It appears that the shares have hit a bottom as the bad news is already price in.
V: 71.75 (-0.22), AXP: 77.01 (-1.98), COST: 145.60 (-0.78), JBLU: 23.22 (-0.30), MA: 95.16 (-1.72)

JetBlue's Newest Route to Turks and Caicos Now on Sale
Marketwired - Mon Jul 20, 7:27AM CDT
JetBlue (NASDAQ: JBLU) today announced that flights on its recently announced new route between Fort Lauderdale-Hollywood International Airport (FLL) and Providenciales International Airport (PLS) in Turks and Caicos are now on sale. The year-round, daily service starts November 19, 2015. JetBlue is offering an introductory fare of only $99 each way (a) between Fort Lauderdale-Hollywood and Turks and Caicos.
JBLU: 23.22 (-0.30)

Court: Airlines get leeway when someone references a bomb
By LARRY NEUMEISTER - AP - Thu Jul 16, 7:08PM CDT
NEW YORK (AP) — Airline employees cannot be held liable if they misinterpret a passenger's reference to a bomb as a threat when they report it to security authorities as long as their statements are not false on key facts, an appeals court said Thursday.
JBLU: 23.22 (-0.30)

Airline Stock Roundup: JetBlue's June Traffic Impresses, American Airlines Trims '15 Capacity Growth View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 15, 10:20AM CDT
It's been a busy week for the airlines sector, with companies like JetBlue Airways (JBLU), United Continental Holdings (UAL), American Airlines Group (AAL), Southwest Airlines (LUV) and Virgin America (VA) revealing their traffic data for June 2015.
VA: 29.72 (+0.17), DAL: 45.16 (-0.06), AAL: 42.61 (+1.18), GOL: 1.68 (-0.13), JBLU: 23.22 (-0.30), UAL: 56.67 (-0.40), LUV: 36.48 (+1.36)

Delta Air Lines and 5 Other Airline Stocks to Buy Now
at The Street - Wed Jul 15, 8:44AM CDT
Lower fuel expenses was the driver of Delta Air Lines' quarterly profit beat, despite declining passenger revenue. Delta is still a buy and so are these five airline stocks.
SAVE: 61.37 (+1.32), DAL: 45.16 (-0.06), JBLU: 23.22 (-0.30), ALK: 73.79 (-2.04), ALGT: 205.05 (+0.05), LUV: 36.48 (+1.36)

Spirit Airlines Cuts Operating Margin Outlook for Q2 & 2015 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 14, 3:35PM CDT
Flight cancellations and pricing pressure led to Spirit Airlines (SAVE) trimming its operating margin outlook.
SAVE: 61.37 (+1.32), JBLU: 23.22 (-0.30), LUV: 36.48 (+1.36)

JetBlue Announces Webcast of Second Quarter 2015 Earnings Conference Call
Marketwired - Tue Jul 14, 3:05PM CDT
JetBlue Airways Corporation (NASDAQ: JBLU) announced today that it will hold its quarterly conference call to discuss second quarter 2015 financial results on July 28, 2015 at 10:00 a.m. ET.
JBLU: 23.22 (-0.30)

Why you should be bullish on Delta Airlines after Iran’s nuclear deal
ESTMZ - Tue Jul 14, 1:10PM CDT
Delta Airlines (DAL) is set to report FQ2 earnings this Wednesday before the opening bell. The Estimize EPS consensus is set at $1.27, 5 cents above Wall Street’s expectations. In terms of revenue, the Estimize consensus is above the Wall Street...
SPY: 210.18 (-1.19), DAL: 45.16 (-0.06), JBLU: 23.22 (-0.30)

JetBlue's (JBLU) June Traffic Increases Y/Y, Stock Gains - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 14, 12:10PM CDT
Low-cost carrier JetBlue Airways Corp. (JBLU) witnessed significant improvement in air traffic in June, this year.
SKYW: 14.93 (-0.30), JBLU: 23.22 (-0.30)

JetBlue (JBLU) Stock Gaining on Mixed Analyst Note
at The Street - Tue Jul 14, 9:25AM CDT
Shares of JetBlue (JBLU) are rising after Barclays raised its 2015 earnings estimates while lowering 2016 earnings estimates.
JBLU: 23.22 (-0.30)

Stock Market News for July 14, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Tue Jul 14, 9:10AM CDT
Benchmarks ended higher on Monday after Greece and its creditors struck a deal for a bailout program
BIIB: 385.05 (-6.69), AMGN: 164.10 (-0.15), JBLU: 23.22 (-0.30), ALK: 73.79 (-2.04), INTC: 28.59 (-0.01), CELG: 139.01 (+0.75), UAL: 56.67 (-0.40), T: 33.93 (-0.34), IBM: 161.73 (+1.38), GILD: 117.66 (+0.22), AAL: 42.61 (+1.18), GOOGL: 674.73 (-20.37), MSFT: 46.11 (+0.57), AAPL: 125.16 (-0.06)

Critical Alerts For Cliffs Natural Resources, JD.com, Kite Pharma, JetBlue and Amazon.com Released By InvestorsObserver
PR Newswire - Tue Jul 14, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for CLF, JD, KITE, JBLU and AMZN.
AMZN: 482.18 (-6.09), KITE: 71.68 (-0.43), JBLU: 23.22 (-0.30), CLF: 2.77 (+0.30), JD: 34.70 (-0.68)

JETBLUE
at Investor's Business Daily - Mon Jul 13, 5:54PM CDT
JETBLUE (JBLU) said its June traffic rose 8.8% and capacity rose 8%. Shares rose 0.2% to 21.95.
JBLU: 23.22 (-0.30)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 6

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 8

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 11

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 12

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 5

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

A Closer Look at Marvell Tech's Upcoming Earnings Release

Updated Category News Views 184

Marvell Tech's Expected Earnings Release Marvell Tech (NASDAQ: MRVL) is set to announce its latest quarterly earnings in December. As investors await this critical financial moment, a brief review of what to expect can shed light on potential impacts and opportunities. Analysts' Earnings Projections Analysts forecast that Marvell Tech will achieve an earnings per share...

Continue Reading
Banijay Group's Recent Share Transactions Update and Insights

Updated Category News Views 222

Recent Share Transactions Overview Banijay Group N.V. (ISIN: NL0015000X07, Bloomberg: BNJ NA, Reuters: BNJ.AS) has reported on its recent share transactions, showcasing the buying and selling activities from the period of September 22 to September 26. Understanding Share Transactions During this timeframe, a mix of buying and selling occurred within the company’s...

Continue Reading
Strategic Growth for Voyageur Mineral Explorers via New Offering

Updated Category News Views 143

Voyageur Mineral Explorers Corp. Secures Massive Funding Voyageur Mineral Explorers Corp. (CSE: VOY) has recently made headlines by completing a significant brokered offering, raising $37.5 million. This financial boost comes at a crucial time for the Company as it seeks to expand its operations and investments in the mineral exploration sector. The offering was executed...

Continue Reading
Applied Materials Faces Challenges Amid Weak Outlook and Stocks

Updated Category News Views 114

Applied Materials Inc. Stock Performance Applied Materials Inc. (NASDAQ: AMAT) recently experienced a noticeable decline in its stock value as the company shared its financial results. After the market closure, the organization revealed its third-quarter earnings, leading to significant concern among investors. The stock's value tumbled, reflecting the market's reaction...

Continue Reading
VFC Class Action Demands Attention: Key Details for Investors

Updated Category News Views 192

Understanding the VFC Class Action Lawsuit Investors in V.F. Corporation, commonly known as VFC, should pay close attention to a pending class action lawsuit that could have significant implications. The law firm Faruqi & Faruqi, a reputable name in securities litigation, has stepped forward to represent affected investors. They are drawing attention to a critical...

Continue Reading